Get the Stockscreener App
13.45
3.31%
-0.46
After Hours:
13.36
-0.09
-0.67%
10 X Genomics Inc stock is traded at $13.45, with a volume of 3.92M.
It is down -3.31% in the last 24 hours and up +16.15% over the past month.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
See More
Previous Close:
$13.91
Open:
$13.695
24h Volume:
3.92M
Relative Volume:
1.04
Market Cap:
$1.49B
Revenue:
$631.73M
Net Income/Loss:
$-239.78M
P/E Ratio:
-6.6584
EPS:
-2.02
Net Cash Flow:
$-33.45M
1W Performance:
-2.04%
1M Performance:
+16.15%
6M Performance:
-10.33%
1Y Performance:
-34.93%
1-Day Range:
$13.29
$14.29
1-Week Range:
$13.29
$14.94
52-Week Range:
$6.78
$24.76
10 X Genomics Inc Stock (TXG) Company Profile
Name
10 X Genomics Inc
Sector
Industry
Phone
(925) 401-7300
Address
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.45 | 1.71B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
284.20 | 46.88B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
56.59 | 10.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.00 | 8.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
58.75 | 11.03B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.17B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-22-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-18-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-10-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-25-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-03-24 | Resumed | Jefferies | Hold |
| May-01-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-10-23 | Initiated | Barclays | Overweight |
| Mar-31-23 | Initiated | Stephens | Overweight |
| Feb-02-23 | Initiated | UBS | Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Aug-18-22 | Downgrade | Goldman | Neutral → Sell |
| Jul-25-22 | Initiated | Canaccord Genuity | Buy |
| Jul-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-15-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-14-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-15-21 | Initiated | William Blair | Outperform |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Overweight |
| Jul-10-20 | Initiated | Stifel | Buy |
| Mar-05-20 | Initiated | Guggenheim | Buy |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-07-19 | Initiated | BofA/Merrill | Buy |
| Oct-07-19 | Initiated | Cowen | Outperform |
| Oct-07-19 | Initiated | JP Morgan | Overweight |
| Sep-24-19 | Initiated | Evercore ISI | Outperform |
View All
10 X Genomics Inc Stock (TXG) Latest News
What are analysts’ price targets for 10x Genomics Inc. in the next 12 monthsStock Market Forecasts For 2025 - jammulinksnews.com
10x Genomics Inc. Price Targets Raised After ReboundWeekly Setup With 3x Return Potential Published - metal.it
10x Genomics Inc. Stock Lags Behind Sector BenchmarksInvestment Plan With Growth Optimization Finalized - beatles.ru
PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know - Yahoo Finance
Why 10x Genomics Inc. stock attracts strong analyst attentionReliable Investment Entry Signals Confirmed by Charts - beatles.ru
RSI and MACD Indicate Shift in 10x Genomics Inc. SentimentEntry Alert Based on Volume Spikes Detected - metal.it
AI Trend Models Suggest Bounce for 10x Genomics Inc.Market Entry and Exit Point Tips From Traders - metal.it
Is 10x Genomics Inc. Starting a New UptrendWealth Building Stock Market Ideas Based on Momentum - beatles.ru
Is it the right time to buy 10x Genomics Inc. stockNavigate the market with precision tools - jammulinksnews.com
Short Covering May Lift 10x Genomics Inc. in Near TermSafe Entry Stock Watch Suggestions for Cautious Traders - metal.it
How volatile is 10x Genomics Inc. stock compared to the marketValue Investing Tracker To Watch Now - jammulinksnews.com
What are 10x Genomics Inc. company’s key revenue driversOutstanding capital appreciation - jammulinksnews.com
What is 10x Genomics Inc. company’s growth strategyTrack stocks with high upside potential easily - jammulinksnews.com
What catalysts could drive 10x Genomics Inc. stock higher in 2025Market Forecast Planner To Watch Now - jammulinksnews.com
Why 10x Genomics Inc. stock attracts strong analyst attention Technical Screener for High Growth Stocks - metal.it
Is 10x Genomics Inc. a growth stock or a value stockBest Dividend Report With High Returns - jammulinksnews.com
What is the risk reward ratio of investing in 10x Genomics Inc. stockUnrivaled growth potential - jammulinksnews.com
What institutional investors are buying 10x Genomics Inc. stockUnlock exclusive stock market insights - jammulinksnews.com
What drives 10x Genomics Inc. stock priceRecord-setting profit potential - PrintWeekIndia
What analysts say about 10x Genomics Inc. stockAccelerated investment success - PrintWeekIndia
Is 10x Genomics Inc. a good long term investmentSpectacular growth rates - Autocar Professional
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know - TradingView
10x Genomics Inc. Stock Analysis and ForecastFree Stock Index Interpretation - jammulinksnews.com
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study - Agency for Science, Technology and Research
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance
10 X Genomics Inc Stock (TXG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
3.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):